These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1310797)

  • 1. Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor-mediated enhancement.
    Somers JP; DeFranco DB
    Mol Endocrinol; 1992 Jan; 6(1):26-34. PubMed ID: 1310797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors.
    DeFranco DB; Qi M; Borror KC; Garabedian MJ; Brautigan DL
    Mol Endocrinol; 1991 Sep; 5(9):1215-28. PubMed ID: 1663212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
    Matkovits T; Christakos S
    Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine.
    Desai RK; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that phosphorylation events participate in thyroid hormone action.
    Jones KE; Brubaker JH; Chin WW
    Endocrinology; 1994 Feb; 134(2):543-8. PubMed ID: 8299553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors.
    Lim-Tio SS; Fuller PJ
    Endocrinology; 1998 Apr; 139(4):1653-61. PubMed ID: 9528946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
    Szapary D; Huang Y; Simons SS
    Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of phosphorylation and transcriptional activity of the glucocorticoid receptor in human synovial fibroblasts by nimesulide, a preferential cyclooxygenase 2 inhibitor.
    Di Battista JA; Zhang M; Martel-Pelletier J; Fernandes J; Alaaeddine N; Pelletier JP
    Arthritis Rheum; 1999 Jan; 42(1):157-66. PubMed ID: 9920026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
    Boruk M; Savory JG; Haché RJ
    Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling.
    Dean DA; Urban G; Aragon IV; Swingle M; Miller B; Rusconi S; Bueno M; Dean NM; Honkanen RE
    BMC Cell Biol; 2001; 2():6. PubMed ID: 11389770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity.
    Taffs RE; Redegeld FA; Sitkovsky MV
    J Immunol; 1991 Jul; 147(2):722-8. PubMed ID: 1649222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
    Wu J; Li Y; Dietz J; Lala DS
    Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest.
    Zuo Z; Urban G; Scammell JG; Dean NM; McLean TK; Aragon I; Honkanen RE
    Biochemistry; 1999 Jul; 38(28):8849-57. PubMed ID: 10413457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment.
    Avenant C; Kotitschke A; Hapgood JP
    Biochemistry; 2010 Feb; 49(5):972-85. PubMed ID: 20047289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB.
    Westermarck J; Lohi J; Keski-Oja J; Kähäri VM
    Cell Growth Differ; 1994 Nov; 5(11):1205-13. PubMed ID: 7848922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.
    Beck CA; Weigel NL; Edwards DP
    Mol Endocrinol; 1992 Apr; 6(4):607-20. PubMed ID: 1316549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
    Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
    Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.